| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/11/2023 | 46.61% | Craig-Hallum | $1 → $1.2 | Maintains | Buy |
| 04/26/2023 | 22.17% | Craig-Hallum | → $1 | Initiates Coverage On | → Buy |
| 05/17/2019 | — | Maxim Group | Downgrades | Buy → Hold |
What is the target price for Xtant Medical Hldgs (XTNT)?
The latest price target for Xtant Medical Hldgs (AMEX: XTNT) was reported by Craig-Hallum on July 11, 2023. The analyst firm set a price target for $1.20 expecting XTNT to rise to within 12 months (a possible 46.61% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Xtant Medical Hldgs (XTNT)?
The latest analyst rating for Xtant Medical Hldgs (AMEX: XTNT) was provided by Craig-Hallum, and Xtant Medical Hldgs maintained their buy rating.
When is the next analyst rating going to be posted or updated for Xtant Medical Hldgs (XTNT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Xtant Medical Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Xtant Medical Hldgs was filed on July 11, 2023 so you should expect the next rating to be made available sometime around July 11, 2024.
Is the Analyst Rating Xtant Medical Hldgs (XTNT) correct?
While ratings are subjective and will change, the latest Xtant Medical Hldgs (XTNT) rating was a maintained with a price target of $1.00 to $1.20. The current price Xtant Medical Hldgs (XTNT) is trading at is $0.82, which is out of the analyst's predicted range.